Jamjoum Ghader, Bahowarth Sarah Y, Alkhalifah Hussain A, Alshehri Nawaf H, Melibari Osman M, Youssuf Wed H, Alshehri Amal A, Metwally Elham M
General Surgery, Hepato-Pancreato-Biliary (HPB) Surgery, Surgical Oncology, King Abdulaziz University Hospital, Jeddah, SAU.
Medicine, King Abdulaziz University Hospital, Jeddah, SAU.
Cureus. 2024 Sep 30;16(9):e70533. doi: 10.7759/cureus.70533. eCollection 2024 Sep.
Introduction Despite Saudi Arabia's' free healthcare system, breast cancer (BC) has a major impact on affected individuals. Previous studies have shown that socioeconomic variables could contribute to inequities in receiving treatment. Although early detection and treatment are essential, delays are frequently influenced by either insurance status or other socioeconomic variables. Assessing characteristics that influence the duration of BC treatment for Saudi women will aid in improving health equity and lowering system costs. Methods This was a cross-sectional study that included all female patients who were diagnosed with BC between 2016 and 2023 at a tertiary care center. All patients were contacted by phone calls to fill out a questionnaire. Results A total of 113 females were included; the mean age at the time of diagnosis with BC was 48.88±10.97 years, and the majority were Saudis (58.4%). Additionally, the median duration for treatment initiation was 28 (15.50-45.50) days from the date of diagnosis. Factors influencing the time for initiating the treatment included nationality, as non-Saudis took longer to receive their treatment (27.00 (13.00-39.25) days vs. 30.00 (18.00-59.00) days, p = 0.176). Moreover, patients living further from the hospital demonstrated a delay in receiving treatment compared to those living near the hospital. However, the relation was not statistically significant. Conclusion Our study investigated the demographic disparities among BC patients. Our results showed that some variables contributed to a delay in treatment initiation, including nationality and distance from the hospital, which suggest further areas for investigation. We recommend further studies be conducted with a larger sample size to improve accessibility and reduce treatment delays for BC patients.
引言 尽管沙特阿拉伯拥有免费医疗体系,但乳腺癌(BC)仍对患者产生重大影响。先前的研究表明,社会经济变量可能导致治疗机会的不平等。虽然早期检测和治疗至关重要,但治疗延迟往往受保险状况或其他社会经济变量的影响。评估影响沙特女性乳腺癌治疗时长的特征,将有助于改善健康公平性并降低系统成本。方法 这是一项横断面研究,纳入了2016年至2023年期间在一家三级护理中心被诊断为乳腺癌的所有女性患者。通过电话联系所有患者以填写问卷。结果 共纳入113名女性;乳腺癌诊断时的平均年龄为48.88±10.97岁,大多数为沙特人(58.4%)。此外,从诊断日期开始,治疗开始的中位时长为28(15.50 - 45.50)天。影响治疗开始时间的因素包括国籍,非沙特人接受治疗的时间更长(27.00(13.00 - 39.25)天对30.00(18.00 - 59.00)天,p = 0.176)。此外,与住在医院附近的患者相比,住得离医院更远的患者接受治疗出现延迟。然而,这种关系无统计学意义。结论 我们的研究调查了乳腺癌患者之间的人口统计学差异。我们的结果表明,一些变量导致了治疗开始的延迟,包括国籍和与医院的距离,这提示了进一步的研究领域。我们建议进行更大样本量的进一步研究,以提高乳腺癌患者的可及性并减少治疗延迟。